Averion's Cardiovascular Clincial Trial Expertise

Averion offers services in the cardiovascular therapeutic area from clinical phase I to phase IV and, to date, has conducted over 130 international studies.   Cardiovascular trials have been conducted in North America, Australia, Israel and throughout Europe. They involved new chemical entities as well as medical devices. We also have experience in the area of gene therapy.

Our strengths in cardiovascular disease come from lead staff that are experienced in the development of cardiovascular disease treatments, our access to opinion leaders and trials networks worldwide, our extensive investigator database and lastly, our global operational expertise in running multi-national trials.

Averion's cardiovasular disease clinical trial experience includes:

Cardiovascular Drug and Biologic Treatments for:

• Arrhythmias (Atrial and Ventricular)
• Cardiogenic Shock
• Dyslipidemia
• Heart Failure (Chronic or Acute)
• Hypertension (Arterial and Pulmonary Arterial)
• Ischemic Heart Disease
  • Angina Pectoris
  • Acute Myocardial Infarction
  • Re-Stenosis
• Stenosis

 Cardiovascular Medical Device, Surgery and Advanced Therapy Expertise:

• Angiogenesis
• Angioplasty (PTCA)
• Arrhythmia Ablation Devices
• Artery Closing Devices
• Biventricular Pacemaker
• Cardiac Adhesion Prevention Device
• Cardiac Imaging
• Cardiogenic Shock Devices
• Circulatory Assist Devices
• Coronary Artery Bypass Graft (CABG)
• Cardiac Pacemakers
• ECG Diagnostic
• Gene Therapy
• Heart Valve Repair/Replacement
• Immune Modulation
• Intracoronary Radiation Therapy
• Implantable Cardiac Defibrillators
• Implantable Replacement Heart
• Percutaneous Ventricular Restoration Implant
• Stem Cell Therapy
• Stents (Coronary and Peripheral)
• Transmyocardial Laser Revascularization
• Vena Cava Filter
• Ventricular Resynchronization